VHT vs. IDNA
VHT (Vanguard Health Care ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds - VHT tracks the MSCI US Investable Market Health Care 25/50 Index while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. Over the past 5 years, VHT returned 4.51%/yr vs -8.42%/yr for IDNA. A 0.67 correlation means they provide meaningful diversification when combined. VHT charges 0.10%/yr vs 0.47%/yr for IDNA.
Performance
VHT vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VHT achieves a -4.02% return, which is significantly lower than IDNA's 10.31% return.
VHT
- 1D
- 0.84%
- 1M
- 1.45%
- YTD
- -4.02%
- 6M
- -4.15%
- 1Y
- 14.34%
- 3Y*
- 6.14%
- 5Y*
- 4.51%
- 10Y*
- 9.26%
IDNA
- 1D
- 0.73%
- 1M
- -2.56%
- YTD
- 10.31%
- 6M
- 8.52%
- 1Y
- 40.87%
- 3Y*
- 6.74%
- 5Y*
- -8.42%
- 10Y*
- —
VHT vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
VHT Vanguard Health Care ETF | -4.02% | 15.46% | 2.66% | 2.52% | -5.60% | 20.57% | 18.29% | 13.45% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 10.31% | 17.26% | -0.72% | -7.63% | -42.28% | -3.98% | 54.30% | 20.83% |
Correlation
The correlation between VHT and IDNA is 0.68, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.68 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.64 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.66 |
Correlation (All Time) Calculated using the full available price history since Jun 14, 2019 | 0.67 |
The correlation between VHT and IDNA has been stable across timeframes, ranging from 0.64 to 0.68 - a consistent structural relationship.
VHT vs. IDNA - Sectors Allocation Comparison
Sectors
VHT
IDNA
Healthcare
Financial Services
-
Industrials
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
VHT
IDNA
Financial Services
VHT
IDNA
-
Industrials
VHT
IDNA
Technology
VHT
IDNA
-
Basic Materials
VHT
-
IDNA
-
Communication Services
VHT
-
IDNA
-
Consumer Cyclical
VHT
-
IDNA
-
Consumer Defensive
VHT
-
IDNA
-
Energy
VHT
-
IDNA
-
Real Estate
VHT
-
IDNA
-
Utilities
VHT
-
IDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VHT vs. IDNA — Risk / Return Rank
VHT
IDNA
VHT vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vanguard Health Care ETF (VHT) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| VHT | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.67 | ||
| Sortino ratioReturn per unit of downside risk | -0.87 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.27 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 1.38 | 3.85 | -2.47 |
| Martin ratioReturn relative to average drawdown | 3.47 | 10.98 | -7.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| VHT | IDNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.00 | 1.68 | -0.67 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.30 | -0.30 | +0.60 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.55 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.56 | 0.10 | +0.46 |
Drawdowns
VHT vs. IDNA - Drawdown Comparison
The maximum VHT drawdown since its inception was -39.12%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for VHT and IDNA.
Loading charts...
Drawdown Indicators
| VHT | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.12% | -68.26% | +29.14% |
Max Drawdown (1Y)Largest decline over 1 year | -10.40% | -10.66% | +0.26% |
Max Drawdown (3Y)Largest decline over 3 years | -16.91% | -29.73% | +12.82% |
Max Drawdown (5Y)Largest decline over 5 years | -17.71% | -68.26% | +50.55% |
Max Drawdown (10Y)Largest decline over 10 years | -28.85% | — | — |
Current DrawdownCurrent decline from peak | -7.05% | -45.61% | +38.56% |
Average DrawdownAverage peak-to-trough decline | -5.99% | -36.24% | +30.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.14% | 3.73% | +0.41% |
Volatility
VHT vs. IDNA - Volatility Comparison
The current volatility for Vanguard Health Care ETF (VHT) is 4.08%, while iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a volatility of 7.18%. This indicates that VHT experiences smaller price fluctuations and is considered to be less risky than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VHT | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.08% | 7.18% | -3.10% |
Volatility (6M)Calculated over the trailing 6-month period | 10.08% | 17.98% | -7.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.34% | 24.48% | -10.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.96% | 28.42% | -13.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.94% | 29.53% | -12.59% |
VHT vs. IDNA - Expense Ratio Comparison
VHT has a 0.10% expense ratio, which is lower than IDNA's 0.47% expense ratio.
Dividends
VHT vs. IDNA - Dividend Comparison
VHT's dividend yield for the trailing twelve months is around 1.71%, more than IDNA's 1.07% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.07% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% | 0.00% | 0.00% | 0.00% | 0.00% |
VHT Vanguard Health Care ETF | 1.71% | 1.61% | 1.53% | 1.36% | 1.33% | 1.14% | 1.21% | 1.89% | 1.38% | 1.31% | 1.45% | 1.22% |
Frequently Asked Questions
VHT and IDNA have a correlation of 0.68, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (7.18%) compared to VHT (4.08%). In terms of maximum drawdown, VHT dropped -39.12% vs IDNA's -68.26%.
On 5-year performance, VHT leads with 4.51% vs -8.42% for IDNA. On fees, VHT is cheaper at 0.10% per year. On volatility, VHT has been the lower-risk option at 4.08%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, VHT has performed better with a 4.51% return vs -8.42%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VHT is cheaper with a 0.10% expense ratio, compared with 0.47% for IDNA.
VHT has the higher dividend yield at 1.71%, compared with 1.07% for IDNA.
VHT tracks MSCI US Investable Market Health Care 25/50 Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: Vanguard and iShares. Their fees differ too: 0.10% for VHT and 0.47% for IDNA.
IDNA currently has the higher Sharpe Ratio (1.68 vs 1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VHT and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer